Task: Answer the multiple choice question.
Question: Which drug exhibits a -33.839% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CN(C)C(C/C=N/OCc1ccc(Cl)cc1)=C(C#N)C#N
b Cc1cc(=O)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12
Answer: a. CN(C)C(C/C=N/OCc1ccc(Cl)cc1)=C(C#N)C#N
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)C(C/C=N/OCc1ccc(Cl)cc1)=C(C#N)C#N
CN(C)C(C/C=N/OCc1ccc(Cl)cc1)=C(C#N)C#N
2-[(3E)-3-[(4-chlorophenyl)methoxyimino]-1-(dimethylamino)propylidene]propanedinitrile